EnviroTech :: Biotech
DSM Biologics to Acquire Rhobust Technology from Danish Firm
10:33 PM MDT | May 4, 2010 | Deepti Ramesh
DSM Biologics says it has reached an agreement with biotech company Upfront Chromatography (Copenhagen, Denmark) for the acquisition of the assets and associated business of Rhobust technology for pharmaceutical and other applications. Financial details of the deal were not disclosed. DSM Biologics will gain all rights for the commercialization of Rhobust technology in various fields including the pharmaceutical industry, through the acquisition. “The acquisition of the Rhobust technology is an important addition to the portfolio of DSM Biologics,”...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee